These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 406272)

  • 41. Serum prolactin in patients with Laron-type dwarfism: effect of insulin-like growth factor I.
    Silbergeld A; Klinger B; Schwartz H; Laron Z
    Horm Res; 1992; 37(4-5):160-4. PubMed ID: 1490658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reduced serum somatomedin activity in patients with chronic liver disease.
    Wu A; Grant DB; Hambley J; Levi AJ
    Clin Sci Mol Med; 1974 Oct; 47(4):359-66. PubMed ID: 4154157
    [No Abstract]   [Full Text] [Related]  

  • 43. Failure of nomifensine to reduce serum prolactin levels in patients with hepatic encephalopathy.
    Masala A; Alagna S; Rovasio PP; Deplano A; Anania V; Chiandussi L; Langer M
    J Endocrinol Invest; 1985 Feb; 8(1):25-9. PubMed ID: 3921593
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Stimulation of growth hormone release by thyrotropin-releasing hormone in elderly subjects.
    Barreca T; Franceschini R; Messina V; Bottaro L; Rolandi E
    Horm Res; 1985; 21(4):214-9. PubMed ID: 4007781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic clearance and plasma half disappearance time of exogenous gonadotropin releasing hormone in normal subjects and in patients with liver disease and chronic renal failure.
    Pimstone B; Epstein S; Hamilton SM; LeRoith D; Hendricks S
    J Clin Endocrinol Metab; 1977 Feb; 44(2):356-60. PubMed ID: 320223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of prolactin and growth hormone responses to 2-deoxy-D-glucose-induced glucoprivation by mazindol in humans.
    Thompson DA; Lilavivat U; Campbell RG
    Metabolism; 1981 Oct; 30(10):1015-20. PubMed ID: 7278648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interrelation between plasma amino acid composition and growth hormone secretion in patients with liver cirrhosis.
    Naomi S; Umeda T; Tajiri J; Inoue J; Hamasaki S; Miura F; Fujii Y; Morita M; Iwaoka T; Sato T
    Endocrinol Jpn; 1984 Oct; 31(5):557-64. PubMed ID: 6440784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Abnormal TSH, PRL and GH response to TSH releasing hormone in patients with severe liver cirrhosis (proceedings) (author's transl)].
    Schilienger JL; Jacques C; Demangeat C; Sapin R; Imler M
    Ann Endocrinol (Paris); 1978; 39(3):245-7. PubMed ID: 102237
    [No Abstract]   [Full Text] [Related]  

  • 49. Increased plasma corticosteroid-binding globulin in insulin-dependent pubertal diabetics: relationships with other glycoproteins, growth hormone and prolactin.
    Angeli A; Ramenghi U; Del Bello S; Gaidano G; Cerutti F; Baratono S
    Acta Diabetol Lat; 1979; 16(4):295-304. PubMed ID: 121658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determinants of serum antipyrine half-lives in patients with liver disease.
    Branch RA; Herbert CM; Read AE
    Gut; 1973 Jul; 14(7):569-73. PubMed ID: 4729926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of IV L-tryptophan on prolactin, growth hormone, and mood in healthy subjects.
    Charney DS; Heninger GR; Reinhard JF; Sternberg DE; Hafstead KM
    Psychopharmacology (Berl); 1982; 78(1):38-43. PubMed ID: 6815695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serial liver function studies following barium enemas containing 1 percent tannic acid.
    Harper RA; Pemberton J; Tobias JS
    Clin Radiol; 1973 Jul; 24(3):315-7. PubMed ID: 4730221
    [No Abstract]   [Full Text] [Related]  

  • 53. Serum somatomedin peptides measured by somatomedin A radioreceptor assay in chronic liver disease.
    Takano K; Hizuka N; Shizume K; Hayashi N; Motoike Y; Obata H
    J Clin Endocrinol Metab; 1977 Oct; 45(4):828-32. PubMed ID: 914986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The kidney is the main site of prolactin elimination in patients with liver disease.
    Bauer AG; Wilson JH; Lamberts SW
    J Clin Endocrinol Metab; 1980 Jul; 51(1):70-3. PubMed ID: 6769942
    [No Abstract]   [Full Text] [Related]  

  • 55. GH/GHBP changes in the perioperative course of liver transplantation: pathophysiologic and clinical implications.
    Cillo U; Bassanello M; Lancerin F; Senzolo M; Burra P; Montin U; Boccagni P; Brolese A; Zanus G; Graziotto A; Russo F; Gringeri E; D'Amico D; De Palo EF
    Transplant Proc; 2001; 33(1-2):1390-2. PubMed ID: 11267341
    [No Abstract]   [Full Text] [Related]  

  • 56. Effect of moderate weight loss on prolactin secretion in normal female volunteers.
    Anderson IM; Crook WS; Gartside SE; Parry-Billings M; Newsholme EA; Cowen PJ
    Psychiatry Res; 1989 Aug; 29(2):161-7. PubMed ID: 2508140
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paradoxical elevation of growth hormone in active chronic hepatitis.
    Becker MD; Cook GC; Wright AD
    Lancet; 1969 Nov; 2(7629):1035-9. PubMed ID: 4187544
    [No Abstract]   [Full Text] [Related]  

  • 58. Decrease in plasma tryptophan after a tryptophan-free amino acid solution. A comparison between cirrhotic and control subjects.
    Moja EA; Rocchi E; Benedetti F; Paolillo F; Casalgrandi G; Ponz de Leon M
    Life Sci; 1991; 48(5):409-18. PubMed ID: 1992283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic effects of mestranol in high dosage.
    Carter AC; Slivko B; Feldman EB
    Steroids; 1970 Jul; 16(1):5-13. PubMed ID: 4097239
    [No Abstract]   [Full Text] [Related]  

  • 60. Association between hypouricaemia and jaundice.
    Schlosstein L; Kippen I; Bluestone R; Whitehouse MW; Klinenberg JR
    Ann Rheum Dis; 1974 Jul; 33(4):308-12. PubMed ID: 4412105
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.